CLEARSIDE BIOMEDICAL, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.32 USD | +3.12% |
|
+3.94% | +12.82% |
| 05-13 | HC Wainwright Adjusts Price Target on Clearside Biomedical to $5 From $6, Keeps Buy Rating | MT |
| 05-09 | Transcript : Clearside Biomedical, Inc., Q1 2024 Earnings Call, May 09, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CLEARSIDE BIOMEDICAL, INC. | Bio Therapeutic Drugs | +3.12% | +3.94% | +12.82% | +23.36% | +4.76% | 95.66M |  | |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- CLSD Stock
- Charts Clearside Biomedical, Inc.
- Comparison Chart